logo
How To Apply Foundation On Mature Skin, According To A Makeup Artist

How To Apply Foundation On Mature Skin, According To A Makeup Artist

NZ Herald13-06-2025

A flawless foundation finish on mature skin? It's within reach, says celebrity makeup artist Rae Morris. The best-selling author and founder of her eponymous makeup brush line shares her top tips.
Foundation formulas have come a long way since the thick, gluggy kind that mask features rather than celebrate them.
Today's top picks go a step further by moving into hybrid territory, with many products moonlighting as skincare thanks to a suite of hydrating ingredients that prioritise skin health as much as they do a flawless finish.
However, the skin changes that come with ageing can mean base products that once promised an airbrushed finish now sit or settle in fine lines.
Not something to be feared but celebrated, Australian makeup artist Rae Morris says evolving our makeup routines to suit the changing needs of mature skin isn't as tricky as some think.
'Mature skin is one of the most beautiful canvases to work on, and with the right preparation and products, it can absolutely glow,' says Rae, who has spent the better part of 25 years creating her signature glowy look on women of every age.
Below, she shares her top tips on how to achieve a hydrated, glowing foundation finish on mature skin types with ease.
1. Hydration is everything
No matter your age, skincare preparation will always be key to giving your makeup the best chance – meaning foundation sits nicely on top of skin, rather than sinking into it.
'Skin should feel plump and juicy before makeup even touches it,' Rae says.
It's natural to experience a drop in collagen, elasticity and moisture as we age, so combatting this with a dose of hydration will always prove an important first step, she adds.
Rich serums, moisturisers and facial oils do the trick, and even the way in which you massage them into skin can help boost radiance and glow.
Consider Charlotte Tilbury Charlotte's Magic Cream, $192, a plumping moisturiser that's long been a backstage favourite, or the L'Oreal Revitalift Filler Plumping Water Cream, $54, which contains micro-particles of hyaluronic acid to re-plump fine lines and wrinkles.
2. Use a brush, not a sponge
For an even, natural finish, Rae recommends using makeup brushes rather than sponges to apply your foundation.
'Sponges aren't suitable for mature skin as they don't blend well around fine lines,' she says.
'A great brush will buff foundation into the skin, making it look seamless and almost invisible. It melts the product in and gives you that smooth, flawless finish.'
Foundation can be applied directly to brush hairs and swirled on to skin, helping to create that polished, airbrushed finish.
Rae says her 'holy grail' of brushes is the Rae Morris Radiance #26, $194, a micro crystal fibre brush, which picks up and evenly disperses liquid, cream and powder formulations with ease.
Otherwise, consider the Mecca Cosmetica All Over Buffing Brush, $44, an ultra-soft brush perfect for buffing in liquid or cream foundation.
3. Forgo glitter textures
While we all know how much fun glitter can be, Rae says to exercise caution when it comes to using anything too sparkly on mature skin.
'Anything with shimmer or sparkle can highlight fine lines, pores, or texture – especially in daylight. This includes primers, foundations, and highlighters,' she says.
Instead, Rae recommends reaching for hydrating, glow-giving formulas that rely on moisture (not shimmer) to deliver on radiance.
For a glow-boosting primer, look no further than M.A.C Studio Radiance Moisturising & Illuminating Silky Primer, $77, which lends a luminous finish to skin – meaning it's perfectly prepped for the makeup steps to follow.
4. Choose skin-enhancing foundations
Rae recommends selecting skin-enhancing foundations or BB creams to help even out skin tone, hydrate, and leave skin with a fresh glow without the weight of full-coverage foundations.
Her top picks for mature skin?
She loves the lightweight, buildable coverage of Giorgio Armani Luminous Silk Foundation, $132, which leaves a radiant finish on all skin types. 'It's iconic for a reason,' she says.
Otherwise, Rae reaches for the Shiseido Synchro Skin Self-Refreshing Foundation, $81, which harnesses the brand's own ActiveForce+ technology to resist heat, humidity, oil and prevent creasing all day long. 'It's great for a more velvety, long-wear option.' .
5. Highlight with cream, not powder
'Put down the shimmer powders,' says Rae, adding that creamy highlights look softer and more natural on mature skin, working gently to hydrate and reflect the light.
'Think balms and glosses on cheekbones and temples to give you a dewy, healthy sheen that looks real – not sparkly.'
Rae loves Elizabeth Arden Eight Hour Cream Skin Protectant, $45, a multi-use cream that works wonders on cuticles, dry spots, chapped lips, and even can be daubed on over makeup in lieu of highlighter.
6. Don't forget the décolletage
'This area shows signs of ageing just like the face and is so often forgotten,' Rae says, adding she loves buffing foundation or bronzing body product on the chest.
Her secret weapon is the Sally Hansen Airbrush Legs, $25, which Rae says 'works brilliantly' when applied with a brush over the décolletage.
'It doesn't transfer and gives that golden-skin effect,' she says.
Tanning drops are also a go-to for Rae, which impart a soft, sun-kissed warmth that ties everything together. Consider the MCo Beauty Self-Tanning Drops For Face & Body, $31.
7. Avoid matte heavy powders
Tread lightly when it comes to powder, as over-mattifying skin can serve to accentuate fine lines or wrinkles.
It can still be your friend, but just be mindful of where you put it – a sheer, light-reflecting powder dusted over the T-zone is enough to set your foundation.
Consider the Laura Mercier Translucent Loose Setting Powder, $85.
Don't like loose powder? No problem – the Rae Morris Invisible Mattifier, $78, is a clear, gel-like powder that can be pressed on to skin using fingers or a small buffing brush to remove unwanted shine (and lasts longer than powder).
'It is completely undetectable no matter your skin tone,' Rae says.
CREDITS
Photographer / Hone Hernandez
Models / Trish Clapham from Silver Fox Management
Hairstylist / Michael Beel
Makeup artist / Shirley Simpson for Aleph Beauty
Stylist / Annabel Dickson
More beauty
From expert tips to individual expression.
Going Grey Gracefully? Expert-Approved Hair Styles To Try If You Have Grey Or Silver Hair. Plus, two stylists share hot tips on the best way to care for and condition grey hair.
'Wearable Cosmetics' Is The Next Trend In Beauty. Here's What You Need To Know. Form meets function in the next wave of beauty products moonlighting as accessories, like perfume pendants and scented bracelets.
Our 2025 Beauty Trend Predictions Came True at Australian Fashion Week. From wine-stained lips to skincare-as-makeup, here are the top trends beauty editor Ashleigh Cometti spotted at AFW.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tonga's Health System Hit By Cyberattack
Tonga's Health System Hit By Cyberattack

Scoop

timea day ago

  • Scoop

Tonga's Health System Hit By Cyberattack

A team of Australian cyber experts flew to Tonga this week after the country's National Health Information System was breached, leading to a demand for payment from the hackers. Talanoa O Tonga reports the Health Minister Dr Ana Akauola saying the system has been shut down, and staff are handling data manually. Dr Akauola said that hackers encrypted the system and demanded payment, but she has assured MPs "the hackers won't damage the information" on the system. This system was introduced in 2019 with Asian Development Bank (ADB) support to digitise Tonga's health records before going "live" in 2021. Police Minister Paula Piukala was critical of past governments for ignoring warnings that Tonga's digital infrastructure is not fully prepared for these threats. Journalist Sifa Pomana said the hackers are demanding millions of dollars, according to Tonga Police. Residents are being urged to bring essential records to the hospital to help with manual record-keeping.

Australasian-led Clinical Trial In Stem Cell Transplant For Blood Cancers Set To Change 40 Years Of Standard Practice
Australasian-led Clinical Trial In Stem Cell Transplant For Blood Cancers Set To Change 40 Years Of Standard Practice

Scoop

time6 days ago

  • Scoop

Australasian-led Clinical Trial In Stem Cell Transplant For Blood Cancers Set To Change 40 Years Of Standard Practice

Leading Australian and New Zealand researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for leukaemia significantly improves patient outcomes post-transplant, reducing the risk of the life-threatening complication of Graft Versus Host Disease (GVHD). The BM12 CAST trial, a major clinical trial led by the Australasian Leukaemia & Lymphoma Group (ALLG) across New Zealand and Australian hospitals, will transform global blood stem cell transplant outcomes for people with high-risk blood cancers like leukaemia. 'This new treatment triples the chances of a patient being alive, healthy and free of GVHD three years after stem cell transplant,' said lead ALLG BM12 researcher, Professor David Curtis, Clinical Haematologist and senior bone marrow transplant physician at The Alfred and Director of Malignant Haematology Research at the Australian Centre for Blood Diseases, Monash University. Blood stem cell transplants are often lifesaving for leukaemia patients, but they come with a high risk of life-threatening complications, especially in the first 100 days after transplant. Common side effects include infections, organ damage, and the often-debilitating Graft versus Host Disease (GVHD), an irreversible lifelong complication. 'The BM12 trial showed the new treatment combination is simple, safe and more effective than current methods in preventing GVHD, which contributes to death or life-long illness in 20% of patients undergoing a blood stem cell transplant,' said Prof Curtis. Results of BM12 trial were published in the New England Journal of Medicine and presented at the European Hematology Association 2025 Meeting in Milan, Italy. These results are game-changing for stem cell transplant patients, with cyclosporin and cyclophosphamide offering a new standard of care for prevention of GVHD for patients with aggressive blood cancers undergoing transplant from a matched related blood stem cell donor. Researchers compared the standard drug combination used for the last 40 years with a new combination of cyclophosphamide and cyclosporin, for leukaemia patients. The new drug combination tripled the number of patients that were alive, cured of the blood cancer and not suffering from GVHD three years after transplant (49.1% vs 14.2% for the standard drug combination). The risk of serious side effects also dropped from 32.4% to 19.7%. The trial's success has immediate implications for clinical practice in the management of blood stem cell transplants. The simplicity and effectiveness of the new treatment, along with reduced toxicity and improved patient outcomes, will become the new standard of care in GVHD prevention for matched sibling transplants. The ALLG BM12 CAST trial's success is particularly important for patients such as Gladys Borgueta, who was diagnosed with Acute Myeloid Leukaemia (AML) and admitted to Auckland Hospital's Motutapu Ward in May 2021. 'Nothing prepares you for an unexpected diagnosis like acute myeloid leukaemia, everything else becomes a blur and your world is turned upside down. Nothing prepares you for the months, weeks in hospital and sometimes in isolation,' said Gladys. ALLG researcher, haematologist Dr Clinton Lewis and colleagues from Auckland Hospital, met with Gladys and suggested the ALLG BM12 trial. 'I knew that the team around me would give me the best care possible. I had however no high expectations just because this was a trial, it could go either way,' Gladys said. Gladys was allocated to the new treatment arm of the BM12 clinical trial and received a stem cell transplant in January 2022. The new drug combination meant that her transplant was successful and she avoided serious side effects such as GVHD. Three years on, Gladys continues to do well after her transplant and is in remission from her leukaemia. 'Without research, I would not have, or for that matter any other patient, benefited from the treatment I got. I feel grateful and blessed to be given a second chance at life.' Auckland Hospital lead investigator, Dr Clinton Lewis, said, 'The results of this exciting study are already changing practice in New Zealand and will continue to improve the lives of cancer patients receiving allogeneic stem cell transplants.' 'Our options for treating Graft versus Host Disease in New Zealand remain very limited compared to other countries, so preventing this complication is incredibly important for our patients.' 'This study shows that we can help our patients live better lives, free of their cancer and GVHD, when we utilise this treatment approach. This sets an improved standard of care in New Zealand', said Dr Lewis. The BM12 CAST trial was funded by the Australian Government's Medical Research Future Fund, the Auckland Medical Research Fund and the Cancer Society of New Zealand.

Do I Have To Pay For My Partner's Care?
Do I Have To Pay For My Partner's Care?

Scoop

time14-06-2025

  • Scoop

Do I Have To Pay For My Partner's Care?

RNZ's money correspondent answers your questions. Send your questions to If one person in a de facto relationship needs permanent medical care, does the Government require the other partner to pay for the care once the unwell patient's funds run out? The basic answer to your question is that when your partner is being assessed for their ability to pay for their care, your income and assets will usually be taken into account. If you're referring to medical care in a rest home setting, your assets and personal income affect whether your partner will qualify for a residential care subsidy. 'People who need residential care are required to pay for it themselves, if they can afford to do so. If they cannot afford it, they may be eligible for a residential care subsidy, which Health New Zealand pays directly to the care provider,' said Ministry of Social Development group general manager for client service delivery Graham Allpress. 'MSD's role is to check whether people qualify for this subsidy by performing a 'financial means assessment'. 'To get the subsidy, a person's income and assets must be under a certain amount. If they are in a relationship, the combined income and assets of both parties must be under a certain amount.' People can qualify for the subsidy if they are 50 to 64, single and without dependent children, or over 65 and meet the income and means test. That means, even if your partner's funds have run out, your assets could still be taken into account. If only one partner needs care, the couple combined need to have assets of no more than $155,873 not including the family home and car, or $284,636 if you do want the home and car in the assessment. If it's other types of care that you're thinking of, it could be a good idea to contact Health NZ for a needs assessment. There are options such as the supported living payment but eligibility for this is assessed on a household income basis, too. I'm currently a NZ tax resident living in NZ, but previously lived in Australia (over a decade ago) and purchased shares on the ASX that I continue to own and receive dividends for (which I declare as part of my income). If I sold these shares now, worth about $150,000, what taxes would they be subject to? Specifically, would I have to pay a capital gains tax on the increased share value (as I would if I were an Australian tax resident). This is probably a question for an accountant with expertise in Australian tax. Based on information available online, it seems that you potentially should have paid tax on the shares in Australia when you stopped being an Australian resident. Assuming that didn't happen, the Australian Tax Office is likely to be expecting capital gains tax to be paid on them when they are sold. You aren't likely to have any New Zealand tax obligations. Tax experts tell me that the authorities have access to a lot of data these days so it's possible that the Australian Tax Office will find out about any share sale and might get in touch with you. I am 78 years of age and still work part time and also still contribute to my KiwiSaver. Am I eligible for the government contribution? Sorry, no. While the government said it was going to start making contributions to 16 and 17-year-olds' accounts, it hasn't budged on the upper limit of 65.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store